Vanderbilt Basic Sciences

  • Dr. James Crowe Jr., professor of medicine, in his lab at Medical Research Building IV. Dr. Crowe is the subject of a feature article in the upcoming Winter 2018 issue of Vanderbilt Magazine. Crowe, who is the Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology, as well as director of the Vanderbilt Vaccine Center, has spent his career hunting for a universal flu vaccine. He has re-engineered how flu vaccines work and is on the edge of creating a single shot that covers all flu strains. In a new initiative announced in October, he will lead an international team of researchers as they launch clinical trials of his new vaccine.(John Russell/Vanderbilt University)

    Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America

    James Crowe Jr., MD, director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization, for his team’s role in developing human monoclonal antibodies and vaccine candidates against COVID-19. The award, which was announced Oct. 6,… Read More

    Oct. 7, 2022

  • Vanderbilt University

    Skaar et al land grant to build top-line biosafety facility

    Vanderbilt University Medical Center has been awarded a nearly $8 million grant from the National Institutes of Health to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms. VUMC currently has two BSL3 labs, but they are small, outdated and… Read More

    Oct. 7, 2022

  • Vanderbilt University

    Lee named 2022 Innovation Fund investigator by The Pew Charitable Trusts

    Dr. Ethan Lee, professor of cell and developmental biology and pharmacology, has been named a 2022 Innovation Fund investigator by The Pew Charitable Trusts. As a vote of confidence in the power of collaborative, interdisciplinary research, Pew created the Innovation Fund in 2017 to encourage partnerships among alumni of Pew’s  biomedical programs. Combining… Read More

    Sep. 28, 2022

  • The best of both worlds: Blending assays to understand human genome regulation

    The best of both worlds: Blending assays to understand human genome regulation

    Assistant Professor of Biochemistry Emily Hodges and graduate student Tyler Hansen used a blended approach to create a new, multi-omic method to identify and characterize gene regulatory elements—non-coding DNA sequences that control gene expression—in the human genome. The new technique, ATAC-STARR-seq, was published in Genome Research. During… Read More

    Sep. 20, 2022

  • Vanderbilt University

    Roden leads effort to map heart disease-causing genetic variations

    One in 100 people have genetic variations that can cause potentially life-threatening heart conditions, including high cholesterol (lipid disorders), heart muscle disease (cardiomyopathies), and abnormal heart rhythms (arrhythmias). Yet the functional impact of most of these cardiovascular genetic variants — whether they disrupt normal function or are harmless — is… Read More

    Sep. 15, 2022

  • Vanderbilt University

    Emily Hodges and Terunaga Nakagawa named 2022 Stanley Cohen Innovation Fund recipients

    The Stanley Cohen Innovation Fund provides a yearly award to support innovative and groundbreaking research at Vanderbilt University. This year, after a competitive application process, Emily Hodges, assistant professor of biochemistry, and Terunaga Nakagawa, associate professor of molecular physiology and biophysics, were named as the 2022 recipients. Read More

    Sep. 15, 2022

  • Headshot of Wenbiao Chen.

    Immune cells drive beta cell loss in Type 2 diabetes

    Obesity and overnutrition increase the risk of Type 2 diabetes through several mechanisms. One of these is through loss of the insulin-producing beta cells of the pancreatic islet.  Wenbiao Chen, PhD, and colleagues previously have shown that overnutrition stressed the endoplasmic reticulum, the part of the beta… Read More

    Sep. 8, 2022

  • Vanderbilt University

    John Wilson to use $3 million grant to develop technology to help cancer patients better fight disease

    John Wilson, associate professor of chemical and biomolecular engineering at Vanderbilt University, has received a $3 million grant from the National Cancer Institute to develop technology that seeks to boost a person’s immune system to better fight cancer. Wilson is the Principal Investigator of the five-year grant. He specializes in… Read More

    Sep. 7, 2022

  • Vanderbilt University

    Alissa Weaver & Matthew Tyska named 2022 ASCB Fellows!

    Alissa Weaver, Professor and Cornelius Vanderbilt Chair, Vanderbilt University, and Matthew Tyska, Cornelius Vanderbilt Professor, Vanderbilt University have been named 2022 ASCB Fellows. “The 2022 ASCB Fellows are individuals who have contributed broadly and significantly to the cell biology community and to the Society. We honor their scientific achievement and their… Read More

    Sep. 2, 2022

  • A simplified interface of a BioRender canvas with several people standing or sitting around the laptop, clicking on it or measuring things. The people are tiny and are not even as tall as the laptop screen itself.

    Basic Science researchers gain access to BioRender Premium

    By Emily Overway Thanks to a partnership between the Vanderbilt University School of Medicine Basic Sciences, the Office of the Vice Provost for Research, and the Office of the Provost, all graduate students, postdoctoral fellows, staff, and primary faculty in Basic Sciences will gain access to BioRender Premium… Read More

    Sep. 1, 2022